Donata holds a BSc in European Public Health from Maastricht University and MSc in Health Economics, Policy and Law from Erasmus University Rotterdam. For her master thesis she developed a cost-effectiveness model for treating relapsed/refractory diffuse large B-cell lymphoma patients in the UK. As a Research Consultant, she supports health economics modelling projects.